Sinochem Holdings: Key Subsidiary Signs Joint Credit Facility Agreement for NT$5 Billion

Release Date: June 24, 2026 Statement Date: June 23, 2026 Statement Time: 16:04:20 Company Code: 3716 Company Name: Sinochem Holdings

Subject: The Company announces that its key subsidiary, China Chemical Pharmaceutical Co., Ltd., has signed a joint credit facility agreement with a syndicate of banks.

Applicable Clause: Clause 10 Factual Date: June 23, 2026

Details: 1. Factual Date: June 23, 2026 2. Counterparty to the Agreement or Commitment: Syndicate of banks including Mega International Commercial Bank and Taipei Fubon Commercial Bank 3. Relationship with the Company: None 4. Effective and Termination Dates (or Release Date) of the Agreement or Commitment: 7 years from the first drawdown date 5. Main Content (not applicable if terminated): Joint credit facility agreement with a total amount of NT$5 billion 6. Restrictive Clauses (not applicable if terminated): As stipulated in the joint credit facility agreement 7. Commitments (not applicable if terminated): As stipulated in the joint credit facility agreement 8. Other Important Agreed Terms (not applicable if terminated): As stipulated in the joint credit facility agreement 9. Impact on the Company's Financial and Business Operations: Strengthening mid-term working capital and optimizing financial structure 10. Specific Purpose: Repayment of existing loans and enhancement of mid-term operational funding 11. Other Matters to be Disclosed (if the subject of the event or resolution is a publicly issued company or above, this significant information also meets the criteria under Article 7, Paragraph 8 of the Enforcement Rules of the Securities Trading Act regarding matters significantly affecting shareholders' equity or securities prices): None